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Abstract  
Genotoxic compounds have induced DNA damage in male germ cells and have 
been associated with adverse clinical outcomes including enhanced risks for 
maternal, paternal and offspring health. DNA strand breaks represent a great threat 
to the genomic integrity of germ cells. Such integrity is essential to maintain 
spermatogenesis and prevent reproduction failure. The Comet assay results 
revealed that the incubation of isolated germ cells with n-ethyl-n-nitrosourea (ENU), 
6-mercaptopurine (6-MP) and methyl methanesulfonate (MMS) led to increase in 
length of Olive tail moment and % tail DNA when compared with the untreated 
control cells and these effects were concentration-dependent. All compounds were 
significantly genotoxic in cultured germ cells. Exposure of isolated germ cells to ENU 
produced the highest concentration-related increase in both DNA damage and gene 
expression changes in spermatogonia. Spermatocytes were most sensitive to 6-MP, 
with DNA damage and gene expression changes while spermatids were particularly 
susceptible to MMS. Real-time PCR results showed that the mRNA level expression 
of p53 increased and bcl-2 decreased significantly with the increasing ENU, 6-MP 
and MMS concentrations in spermatogonia, spermatocytes and spermatids 
respectively for 24 h. Both are gene targets for DNA damage response and 
apoptosis. These observations may help explain the cell alterations caused by ENU, 
6-MP and MMS in spermatogonia, spermatocytes and spermatids. Taken together, 
ENU, 6-MP and MMS induced DNA damage and decreased apoptosis associated 
gene expression in the germ cells in vitro. 
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Introduction  
Spermatogenesis is a highly organized and a complex process that is characterized 
by stem-cell renewal, reorganization, genome repackaging and production of 
differentiated daughter cells to provide a continual supply of spermatozoa [Oatley et 
al. 2004]. Defects or delay at all stages of the spermatogenesis process lead to 
infertility, but few of them can be modelled in vitro or in cell culture. Targeted 
mutagenesis in mice offers great tools to investigate these stages, and study the 
impact of gene function on specific stages and thus has provided novel insights into 
the origins of male infertility [Cooke and Saunders 2002; Yauk et al. 2015].  Animal 
models have also been extensively used to study normal spermatogenesis and have 
revealed various critical molecular mechanisms that determine whether genetic 
damage persists in the germline [Jan et al. 2012]. Alkylating agents affect the 
mammalian genome by forming DNA lesions, and thus causing base substitution 
mutations, or preventing DNA replication [Imai et al. 2000; van Boxtel et al. 2010]. 
However, ENU has been shown to be a potent alkylating agent inducing germ cell 
line mutation due to its strength and preferential activity in spermatogonial stem cells 
[Caignard et al. 2014]. It has also been shown that germ cells treated with 6-MP 
have the greatest response in early meiotic spermatocytes [Generoso et al. 1975; 
Norgard et al. 2016]. MMS has also been found to induce a high incidence of 
dominant lethal mutations in spermatids [Ehling 1971]. Our previous study [Habas et 
al. 2016], using the Comet assay in rat, also showed that ENU produced a high level 
of DNA damage in spermatogonia incurring significantly greater DNA damage. 
Spermatocytes were most sensitive to 6-MP while spermatids were particularly 
susceptible to MMS [Habas et al. 2016]. This present study aimed to assess the 
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phase specificity of the susceptibility of spermiogenic germ cells in mice to genetic 
damage induced by ENU, 6-MP and MMS in vitro.  
Materials and Methods 
Animals 
Male adult National Medical Research Institute (NMRI) mice (10-12 weeks old; 
weighing 25–30 g), derived from the original stocks obtained from the Institute of 
Cancer Therapeutics Laboratories, were maintained under standard conditions with 
free access to food and water at the Animal Facility of the University of Bradford, UK. 
All animal care procedures were carried out according to the National Research 
Council's Guide for the Care and Use of Laboratory Animals.  
Cell Isolation and Culture. 
The method for isolation of testicular germ cells was described previously for the 
mouse [Habas et al. 2014]. Briefly, six testes were collected from three adult NMRI 
mice  (10-12 weeks old), decapsulated, and the seminiferous tubules placed into ice 
cold Dulbecco’s Modified Eagle’s medium (DMEM), dispersed by gentle pipetting, 
minced and resuspended in fresh DMEM containing collagenase (5mg/ml) and 
DNase (1μg/ml) (both from Sigma, Poole, UK), then incubated at 32°C for 20 min. 
The cells were left to stand for 5 min before being filtered through an 80μm nylon 
mesh (Tetco Inc., Briarcliff Manor, NY), centrifuged at 600 × g for 10 min and bottom-
loaded into the separation chamber of a Staput apparatus in a volume of 10ml. A 2-
4% w/v concentration gradient of bovine serum albumin (BSA) (Sigma, Poole, UK)  
was then generated below the cells, which were allowed to sediment for a standard 
period of 2.5 h before 31, 12 ml fractions were collected at 60s intervals. The cells in 
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each fraction were examined under a phase contrast microscope, and consecutive 
fractions containing cells of similar size and morphology were collected by low-speed 
centrifugation and resuspended in DMEM.  
Isolation and morphological characteristics of mouse spermatogonia, spermatocytes 
and spermatids 
The identity and purity of all cell preparations used in the experiments were 
confirmed by immunohistochemistry for phase-specific markers exactly as described 
previously [Habas et al. 2014]. The viabilities of the freshly isolated spermatogonia, 
spermatocytes and spermatids were over 98%, as evidenced by trypan blue 
exclusion of these cells. Immunocytochemical analysis revealed that the range of 
purities of the cells from the spermatogonial fractions was 87% − 90% across the 3 
independent experiments that were performed. For spermatocyte fractions, it was 
88–90% and 88–92% for the spermatid fractions. The results also were confirmed by 
Western blotting for phase-specific markers exactly as described previously [Habas 
et al. 2016]. 
Treatment of Isolated Germ Cells with Chemicals 
Germ cell suspensions (1.5 − 2.5 × 105 cell/ml) were suspended in 1 ml sterile fresh 
RPMI medium. One hundred μl of mixed germ cells were then added to each 
treatment tube (100 μl mixed germ cells, 890 μl RPMI medium, plus 10 μl of 
chemical or 900 μl RPMI for the negative control). Cells were treated with ENU, 6-
MP and MMS at a final concentration of (0, 0.05, 0.5, and 1 mM) and all samples 
were incubated for 1 h at 37°C, 5% CO2. Solvent controls were used for the 0 mM 
dose level. Therefore, due to the length of exposure used in the current study (1h for 
the Comet assay and 24 h for qPCR assay), the concentrations of ENU, 6-MP and 
6 
 
MMS were adjusted to the 0.05 mM – 1 mM range to ensure cell viability remained 
largely unaffected whilst still producing a cellular response to chemical exposure in 
spermatogonia, spermatocytes and spermatids respectively. The treated and 
untreated germ cells were used in the Comet assay and qPCR assay. 
Determination of Cytotoxicity with Cell Counting Kit-8 (CCK-8) Assay  
Cell viability was determined using a modified cell counting kit-8 (CCK-8) Cytotoxicity 
Assay (Sigma-Aldrich, UK). Spermatogonia, spermatocytes and spermatids were 
plated in a 96-well plate at a concentration of 5000 cells per well. Ten µl of different 
concentrations of ENU, 6-MP and MMS (0, 0.05, 0.5 and 1 mM) was added into the 
culture media in the plate. Cells were pre-incubated for 24 h in a humidified incubator 
at 37 °C, 5% CO2. Ten µl of CCK-8 solution was added to each well of the plate, 
followed by incubation at 37 °C for 4 h. Absorbance was measured at a wavelength 
of 450 nm using a Microplate reader MRX II (Dynex Technologies, Chantilly, USA). 
The Comet Assay 
The Comet assay was used for assessing the DNA damage in spermatogonia, 
spermatocyte and spermatid cells after ENU, 6-MP and MMS treatment. 
Approximately 2 x 105 germ cells were suspended in Eppendorf® tubes and 
incubated with ENU, 6-MP and MMS at final concentrations of 0, 0.05, 0.5, and 1 
mM, and grown in 5% CO2 and 95% air at 37°C. Cell debris was removed and cells 
remaining in the plates from each treatment were harvested by centrifugation and 
then used for the examination of DNA damage using the Comet assay as described 
previously [Habas et al. 2016]. Olive tail moment (OTM) and % tail DNA were 
measured, calculated, quantified and expressed (fold of control) in mean ± S.D (n=3)  
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for isolated germ cells using the (Comet 6.0; Andor Technology, formerly Kinetic 
Imaging) software image analysis system,  Belfast, UK. 
Quantitative Real-Time PCR Assay 
Real-time PCR of p53 and bcl-2 genes in cells of spermatogonia, spermatocytes and 
spermatids after ENU, 6-MP and MMS treatment respectively were examined. 2×105 
cells/well in 6-well plates were incubated with 0, 0.05, 0.5 and 1 mM of ENU, 6-MP 
and MMS for 24 h. The cells from each treatment were harvested by centrifugation 
and the total RNA was extracted using TRIzol® following the manufacturer's 
(Invitrogen) manual and RNA quantity and quality were checked by OD260/280 
measurements. To remove any genomic DNA, the RNA was treated with DNase I 
(Sigma–Aldrich) according to the manufacturer's instructions. Random hexamer 
primed reverse transcription reactions were performed for 400 ng of total RNA in a 
20 μl setup using ImProm-II™ Reverse Transcription System reaction following the 
manufacturer's instructions (Promega). The synthesised cDNA samples were diluted 
1:10 in nuclease free water and stored at −20 °C. Each assay was run on 
StepOnePlus™ real-time PCR instrument (Applied Biosystems) in triplicate and 
expression fold-changes were derived using the comparative CT method. 
Statistical Analysis 
Data are expressed as mean ± SEM of at least three independent experiments with 
three replicates per experimental group. Comparisons were made by one-way 
ANOVA followed by Bonferroni post hoc test; for all experiments, a P value of <0.05 
was considered significant. 
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RESULTS  
The cytotoxicity assay using the CCK-8 kit was performed to directly determine the 
effect of ENU, 6-MP and MMS on cellular viability of spermatogonia, spermatocytes 
and spermatids respectively under our laboratory conditions. Spermatogonia, 
spermatocytes and spermatids respectively were either treated with different 
concentrations of ENU, 6-MP and MMS (0, 0.05, 0.5 and 1 mM) or left untreated and 
considered as control. The results showed that ENU, 6-MP and MMS at the 
concentrations 0, 0.05, 0.5 and 1 mM had no significant effect on cell viability (Data 
not shown). In addition the viabilities of the freshly isolated spermatogonia, 
spermatocytes and spermatids were routinely >98%, as evidenced by trypan blue 
exclusion of these cells (Phillips, 1973). The germ cells were cultured overnight at 
37°C. The following day, viability was re-checked and the cells treated with the 
mutagens ENU, 6-MP and MMS. Viabilities were checked again and were found to 
be routinely >90% for cells that had been exposed to ENU, 6-MP and MMS. They 
were then used immediately for qPCR and the Comet assay. The different types of 
cells varied in their ability to respond to the three chemicals. Spermatogonia were 
most sensitive to ENU, with both DNA damage and gene expression changes (p53 
upregulation and bcl-2 downregulation) significant at 0.05 mM (Table I, Figs 1 and 2 
and Figs 3 A and B). It was also shown that spermatogonia had a significant effect in 
both assays, when treated with 0.5 and 1 mM 6-MP and MMS. This reflects the 
amount of actively dividing cells in these cell types, suggesting a possible 
mechanism for the differential sensitivity. There were concentration-dependent 
increases in both assays for 6-MP. The concentration that induced a statistically 
significant increase in genetic damage was 0.[Anderson, 1981 #209]5 mM 6-MP for 
DNA damage, and 0.5 mM 6-MP for upregulation of p53 and downregulation of bcl-2 
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mRNA expression (Table I, Figs 1 and 2 and Figs 4 A and B). These results illustrate 
that there is good agreement with data showing that in vivo, 6-MP is a potent 
compound for inducing DNA damage in spermatocytes. 
Spermatids were the most sensitive cell type to MMS, with both DNA damage and 
gene expression changes (p53 upregulation and bcl-2 downregulation) significant at 
0.05 mM, 0.5 mM and 1 mM (Table I, Figs 1 and 2 and Figs 5 A and B). Three 
compounds were significantly genotoxic in cultured male germ cells. 
DISCUSSION 
Mutant frequencies in male rat germ cells were determined after exposure to ENU, 
MNU, 6MP, 5BrdU, MMS and EMS and thus have been reported to cause specific 
DNA damage in isolated germ cells from adult rat testis [Ehling et al. 1978; Anderson 
et al 1981; Anderson et al. 1997; Russell et al. 2007; Levkoff et al. 2008; Kanemitsu 
et al. 2009; Habas et al. 2016]. To examine species differences in the DNA damage 
between rats and mice three male germ cell mutagens (ENU, 6-MP and MMS) were 
selected for testing. Numerous strategies for the evaluation of reproductive 
genotoxicity of chemical compounds have been proposed. In the present study, we 
developed experimental in vitro assays to test the effect of potential toxicants on 
male mouse germ cells in vitro using recently developed methods for isolation and 
culture of adult rats.  In fact, there is no recently reliable cell culture system allowing 
for spermatogenic differentiation in vitro, and most biological studies of 
spermatogenic cells require tissue harvest from animal models like the mouse and 
rat [Bryant et al. 2013]. Although a reproductive toxicity study has shown that 
spermatogenesis is a very complex process of which only some stages can be 
reconstructed in vitro. Our study of an in vitro model of spermatogenic cells could 
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make it easier to understand the mechanisms underlying spermatogenic cell 
differentiation with potential for extrapolation to humans in which experimental 
approaches are not possible. It could also be used cells isolated from human 
cadavers. In addition isolated germ cells could greatly improve and make the actual 
procedures of assisted reproductive technology more efficient and help to develop 
alternative infertility treatments. The differences in composition and metabolism 
between different types of male germ cells led to differing susceptibilities to 
genotoxicity and mutation induction. This is an important toxicological consideration, 
especially if any in vitro study is to be undertaken. This also can provide vital 
evidence about the possible mechanisms included in genotoxicity and therefore 
increases the significance of the findings [Habas et al., 2016].  
In this present study, we examined DNA-strand breakage induced by ENU, 6-MP 
and MMS and regulation of the DNA damage response in mouse testicular cells. 
These three chemicals are well established as reproductive genotoxins and showed 
clear cell-type specificity in vivo and in vitro on isolated germ cells from rat testis 
[Habas et al, 2016]. Genotoxicity assessment in isolated male mice germ cells after 
exposure to ENU, 6-MP and MMS was conducted using the alkali version of the 
Comet assay to detect DNA strand breaks and the level of expression of regulated 
genes p53 and bcl-2 for apoptosis were quantified by real-time reverse transcription-
PCR (RT-PCR).  
Major differences were observed between different cellular phases of mouse 
spermatogenesis. Spermatogonia were the most sensitive to ENU; spermatocytes 
were most sensitive to 6-MP while spermatids were the most sensitive cell type to 
MMS.  DNA lesions induced by exposure to 6-MP was higher in rat spermatocytes 
compared to mouse spermatocytes, indicating major differences in sensitivity 
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between the two species. The Comet assay results significantly indicate that these 
results match the positive results found in vivo and the cell-type specificity of ENU, 6-
MP and, MMS found in vivo was the same as that which we found with our in vitro 
system in rat. We have previously reported that treatment of the isolated germ cells 
from adult rat testis with ENU produced the greatest concentration-related increase 
in DNA damage in spermatogonia [Habas et al 2016]. There is no prior information to 
show that ENU inhibited DNA gene expression in spermatogonial cells more than 
spermatocytes and spermatids and so was investigated in the present study. We 
also confirmed that ENU upregulation of p53 and downregulation of bcl-2 mRNA 
expression was greatest in spermatogonia. The ENU is extremely mutagenic, and 
induces apoptosis after S-phase accumulation of p53 in response to DNA damage 
[Katayama et al. 2002]. The level of p53 mRNA was increased similarly, and also in 
a concentration-dependent manner in the spermatogonia with the lowest 
concentration of ENU. This was not detected in other cell types, namely 
spermatocytes or spermatids; mRNA expression of bcl-2 was also decreased in 
spermatogonia more than in spermatocytes and spermatids when treated with the 
lowest concentration of ENU. This result confirms that of a previous study in vivo, in 
which differentiating spermatogonial cells were observed to be the most sensitive 
testicular cells to ENU damage, due to their higher mitotic rate compared to other 
spermatogenic cells [Russell et al. 2007]. The data presented here show that the 
expression level of p53 is high in spermatogonial cells compared to levels in 
spermatocytes and spermatids; a potential consequence of actively dividing 
spermatogonia which are the most susceptible male germ cell. Spermatids also 
show some increased expression of p53, yet are non-cycling, differentiating cells 
with limited DNA repair capacity. Thus it may be that although p53 is a 
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multifunctional protein, the principal role of the increased expression observed is to 
trigger apoptosis. The decreased expression of bcl-2 and induction of apoptosis 
were both shown in parallel to the increase in p53, which in turn also reflected the 
induction of DNA damage shown in the Comet assay. 
A similar trend was observed in the spermatocytes, which illustrated a highly 
significant increase in DNA damage and p53 expression was significantly increased 
after 6-MP treatment, whereas bcl-2 was reduced greatly after exposure to 6-MP. In 
animal models, 6-MP has been shown to cause chromosomal damage and 
aberrations in the spermatocytes [Russell and Hunsicker 1987]. The cytogenetic 
study of spermatocyte cells at diakinesis showed a significant increase in 
isochromatid and chromatid deletions on days 14 and 15 after treatment with 6-MP 
[Generoso et al. 1975]. This suggested that the cell exposure during this time may 
have been in early meiosis preleptotene spermatocytes stage. 6-MP has been found 
to act mainly on rapidly dividing cells (i.e. in the later stages of spermatogenesis) 
[Maltaris et al. 2006]. It also has shown that 6-MP caused chromosomal damage and 
aberrations in the spermatocytes [Russell and Hunsicker 1987]. Therefore, 
spermatocytes were highly sensitive to 6-MP. The results of our in vitro experiments 
are in agreement with the results in vivo that suggested that 6-MP is a potent 
compound for inducing DNA damage in spermatocytes [Mosesso and Palitti 1993].  
Between rodents, it’s well-established that mice are the most commonly used animal 
model for studying human disease germ cell differentiation, sex determination and 
genetics. Study by Encinas et al (2012) who compared the rat and mouse germ cell 
development, particularly on some germ cells markers including germ cell nuclear 
antigen 1 (GCNA1), OCT4, mouse vasa homologue (MVH) and specific surface 
embryonic antigen 1 (SSEA1) were immunolabeled at different phases of embryonic 
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and postnatal development (Encinas et al., 2012), comparable to our study. 
Therefore, the level of DNA damage is dependent on both the gentoxicant and the 
type of germ cells. Also these differential responses to induced DNA damage may 
contribute to the difference in susceptibility to these three compounds in these three 
types of cells and species. In this present study, we found that the DNA lesion 
induced by exposure to 6-MP was higher in rat spermatocytes compared to mouse 
spermatocytes, indicating major difference in sensitivity between two species. Given 
the results of the present study in mouse, we note that 6-MP at 0.05 mM produced 
significantly induced DNA damage in rat, but not in mice. One possible explanation 
for the difference in sensitivity seen between mouse and rat could be a lower 
spermatogenic recovery in rat but also the rat may be more sensitive to testicular 
damage after treatment with this compound than mice. So, we suggest that the rat is 
also a very important model for the investigation of the mechanisms and 
susceptibility of germ cells to genotoxicity. After MMS treatment, the sensitive 
cellular stage for induction of sperm morphological abnormalities was judged to be 
late spermatids [Kuriyama et al. 2005]. These results also indicated that all three 
compounds induced DNA damage in isolated germ cells in mouse as well as shown 
earlier in rat so strengthening the rodent data base. A combination of the Comet 
assay and qPCR can offer more information relating to biological function in sperm 
perhaps leading to male infertility.  
CONCLUSION 
The level of gene expression in response to DNA damage in mouse is dependent on 
the gentoxicant and the type of germ cells in vitro, following concentrations known to 
be related to testicular and reproductive toxicity in vivo. These results indicate that 
Staput isolated mouse testicular germ cells provide a suitable model in vitro to study 
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DNA damage and regulation of either pro-apoptotic or anti-apoptotic gene 
expression in different phases of the spermatogenic cycle. The high correlation 
between the in vivo data and the present results indicate this approach could have 
the possibility to be scaled up into a screen for genetic effects on reproductive cells 
in vitro 
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 Figure Legends  
Figure 1: Induced DNA damage in germ cells after treatment with ENU, 6-MP and 
MMS at different concentrations 0, 0.05, 0.5 and 1 mM for 1 h. OTM was used for 
DNA damage quantification. (*P <0.05, **P <0.01, *** P <0.001 when compared with 
the respective control group). 
Figure 2: Induced DNA damage in germ cells after treatment with ENU, 6-MP and  
MMS at different concentrations 0, 0.05, 0.5 and 1 mM for 1 h. %tail DNA was used 
for DNA damage quantification. (*P <0.05, **P <0.01, *** P <0.001 when compared 
with the respective control group). 
Figure 3 A and B: Concentration-dependent effects of ENU on p53 and bcl-2 mRNA 
expression levels in spermatogonia, spermatocytes and spermatids, treated with 
different concentrations of ENU 0, 0.05, 0.5 and 1 mM mRNA expression levels were 
determined by qPCR. β-actin mRNA was used as an internal control. The data 
shown are representative of three independent experiments. The significant 
differences from control are indicated by *P < 0.05, **P < 0.01, ***P < 0.001. 
Figure 4 A and B: Concentration-dependent effects of 6-MP on p53 and bcl-2 mRNA 
expression levels in spermatogonia, spermatocytes and spermatids, treated with 
different concentrations of 6-MP 0, 0.05, 0.5 and 1 mM. mRNA expression levels 
were determined by qPCR. β-actin mRNA was used as an internal control. The data 
shown are representative of three independent experiments. The significant 
differences from control are indicated by *P < 0.05, **P < 0.01, ***P < 0.001. 
Figure 5 A and B: Concentration-dependent effects of MMS on p53 and bcl-2 mRNA 
expression levels in spermatogonia, spermatocytes and spermatids, treated with 
different concentrations of MMS 0, 0.05, 0.5 and 1 mM. mRNA expression levels 
were determined by qPCR. β-actin mRNA was used as an internal control. The data 
shown are representative of three independent experiments. The significant 
differences from control are indicated by *P < 0.05, **P < 0.01, ***P < 0.001. 
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Table I. Individual data for the effects of ENU, 6-MP and MMS on isolated germ cells 
measured using the comet parameters: OTM and % tail DNA. Data shown represent 
group values (mean ± SEM) of three experiments (100 cells scored per experiment) 
 
Germ cells Olive tail moment (%)Tail DNA  
Spermatogonia     
Control 1.23 ± 0.06 7.23 ± 0.33 
0.05mM ENU 2.33 ± 0.13 ** 8.37 ± 0.21  ** 
0.5mM   ENU 6.21± 0.49 *** 21.29 ± 1.51*** 
1mM      ENU 9.29 ± 0.20*** 26.10 ± 0.64*** 
Spermatocytes    
Control 0.91 ± 0.08 4.97 ± 0.35 
0.05mM   ENU 1.35 ± 0.23 ns 7.28 ± 0.65 ns 
0.5mM     ENU 3.01 ± 0.15 * 12.73 ± 1.15* 
1mM        ENU 3.78 ± 0.21** 15.45 ± 1.27** 
Spermatids   
Control 0.59 ±  0.05 4.50 ± 0.35 
0.05mM    ENU 0.75 ±  0.09 ns  7.21±  0.69 ns 
0.5mM      ENU 1.87 ± 0.37 *  9.82 ± 0.92 * 
1mM         ENU 2.66 ± 0.28**  13.42 ± 0.85 ** 
Spermatogonia     
Control 0.90 ± 0.07 3.93 ± 0.27 
0.05mM 6-MP 1.35 ± 0.29 ns 5.26 ± 0.96 ns 
0.5mM   6-MP 1.77 ± 0.15* 7.57 ± 0.54* 
1mM      6-MP 2.74 ± 0.14** 10.67±  0.97** 
Spermatocytes    
Control 0.86 ± 0.08 4.04 ±  0.58 
0.05mM   6-MP 1.66 ± 0.27 ns 7.15 ± 0.47ns 
0.5mM     6-MP 3.44 ± 0.33** 12.99 ± 1.15** 
1mM        6-MP 5.01 ± 0.18*** 17.43 ± 0.90*** 
Spermatids   
Control 0.85 ± 0.09 4.02 ± 0.60 
0.05mM    6-MP 1.60 ± 0.28ns  6.10 ±  0.99ns 
0.5mM      6-MP 2.08 ± 0.33*  7.87 ± 1.06* 
1mM         6-MP 3.00 ± 0.46**  11.94 ± 1.73** 
Spermatogonia     
Control 0.99 ± 0.04 3.96 ± 0.24 
0.05mM MMS 2.03 ± 0.44 ns  7.64 ± 0.92ns 
0.5mM    MMS 4.48 ± 0.63* 10.69 ± 1.06* 
1mM       MMS 5.24 ± 0.79** 17.63 ± 1.92** 
Spermatocytes    
Control 1.07 ± 0.12 4.59 ± 0.94 
0.05mM    MMS  1.90 ± 0.10 * 10.75 ± 0.94* 
0.5mM      MMS 4.85 ± 0.68** 11.93 ± 1.75** 
1mM         MMS 6.48 ± 0.85** 18.82 ± 1.16** 
Spermatids   
Control 1.18 ± 0.37 4.91 ± 0.62 
0.05mM     MMS 3.31 ± 0.30 **  13.01± 1.00 ** 
0.5mM       MMS 8.84 ± 1.08***  26.78 ± 0.86*** 
1mM          MMS 12.00 ± 1.05***  37.30 ± 1.41*** 
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Figure 1  
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Figure 2 
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Figure 3 A and B 
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Figure 4 A and B 
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Figure 5 A and B 
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